Combigene AB (COMBI) — Cash Flow Reinvestment Rate
Latest as of September 2022:
0.00x
Combigene AB (COMBI) has a Cash Flow Reinvestment Rate of 0.00x as of September 2022, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr379.00K. Check how high is Combigene AB's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr379.00K
SEK
Capital Expenditures
Skr0.00
SEK
Combigene AB Cash Flow Reinvestment Rate (2012–2021)
Historical reinvestment intensity for Combigene AB across 3 annual periods. Explore COMBI cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Combigene AB (2012–2021)
Year-by-year capital reinvestment analysis for Combigene AB. For live market cap and broader valuation context, see Combigene AB market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.01x | Skr295.46K | Skr22.11 Million | Skr147.73K | ▼ -99.6% |
| 2018 | 3.78x | Skr860.40K | Skr227.60K | Skr430.20K | — |
| 2012 | 0.00x | Skr0.00 | Skr59.21K | Skr0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow